Article
Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget’s Disease of the Vulva
15 Sept 2020
Abstract excerpt
PURPOSE: To identify genomic alterations as potential therapeutic targets in extramammary Paget disease (EMPD) of the vulva. METHODS: We identified all patients with primary vulvar EMPD who were treated at our institution and underwent paired tumor-normal massively parallel sequencing of 410-468 cancer-related genes (MSK-IMPACT assay). EMPD of the vulva samples sequenced from 2014 to 2019 were reviewed and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
